Sun Pharmaceutical Industries Limited (SUNPHARMA) Share Price
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE044A01036
Key metrics
- Market Cap
- ₹4.58 L Cr
- P/E Ratio
- 38.16
- EPS
- 50.01
- Book Value
- 349.6
- P/B Ratio
- 5.46
- ROE
- 13.69%
- ROCE
- 15.36%
- Debt / Equity
- 0.06
- Net Margin
- 19.72%
- Revenue Growth
- 11.87%
- Profit Growth
- 5.04%
- Dividend Yield
- 0.83%
- 52W High
- ₹2,046.90
- 52W Low
- ₹1,548.00
- Market Cap Band
- large cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.
- Headquarters
- Mumbai, India
- Employees
- 47,000
- Promoter Holding
- 55.61%
The full Sun Pharmaceutical Industries Limited analysis
Create a free account to open the complete SUNPHARMA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.